Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Defining antimicrobial resistance in cystic fibrosis

Research output: Contribution to journalReviewResearchpeer-review

  1. Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Antibody response against Mycobacterium avium complex in cystic fibrosis patients measured by a novel IgG ELISA test

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The choice of lung function reference equation affects clinical trial eligibility: Results from a cystic fibrosis cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. IgG avidity to Pseudomonas aeruginosa over the course of chronic lung biofilm infection in cystic fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Privatisation rescues function following loss of cooperation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Treatment of candidemia in a nationwide setting: increased survival with primary echinocandin treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Human genetic variation in GLS2 is associated with development of complicated Staphylococcus aureus bacteremia

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The accessibility of topical treatment in the paranasal sinuses on operated cystic fibrosis patients assessed by scintigraphy

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Antimicrobial Resistance in Cystic Fibrosis International Working Group
  • Helle Krogh Johansen (Member of study group)
View graph of relations

Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.

Original languageEnglish
JournalJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Volume17
Issue number6
Pages (from-to)696-704
Number of pages9
ISSN1569-1993
DOIs
Publication statusPublished - Nov 2018

ID: 56201233